CYTOO
Pre-clinicalPioneering muscle pathology research with our exclusive MyoScreen platform to accelerate drug target identification and therapeutic innovation.
Founded
2005
Focus
Cell TherapyDrug Delivery
About
Pioneering muscle pathology research with our exclusive MyoScreen platform to accelerate drug target identification and therapeutic innovation.
Funding History
2Total raised: $10.5M
Series A$8MUndisclosedJun 15, 2017
Seed$2.5MUndisclosedJun 15, 2015
Company Info
TypePrivate
Founded2005
LocationGrenoble, France
StagePre-clinical
Contact
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile